参考文献/References:
[1] Yu HS,Liu ZM,Yu XY,et al.Low-dose radiation induces antitumor effects and erythrocyte system hormesis[J].Asian Pacific Journal of CancerPrevention,2013,14(7):4121-4126.
[2] 梁 亮,张寅斌,马宇光,等.miR-25对三阴性乳腺癌细胞增殖和凋亡的影响及潜在机制[J].现代肿瘤医学,2016,24(20):3197-3201.
Liang L,Zhang YB,Ma YG,et al.The effect of miR-25 on proliferation and apoptosis of triple negative breast cancer cells and the potential mechanism[J].Modern Oncology,2016,24(20):3197-3201.
[3] Xie CM,Wei W,Sun Y.Role of SKP1-CUL1-F-Box-Protein(SCF)E3 ubiquitin ligases in skin cancer[J].Journal of Genetics and Genomics,2013,40(3):97-106.
[4] Wei C,Liu J,Yu Z,et al.TALEN or Cas9-rapid,efficient and specific choices for genome modifications[J].Journal of Genetics and Genomics,2013,40(6):281-289.
[5] Mo Z,Zu X,Xie Z,et al.Antitumor effect of F-PBF(beta-TrCP)-inducedtargeted PTTG1 degradation in HeLa cells[J].Journal of Biotechnology,2009,139(1):6-11.
[6] Hudes GR,Carducci MA,Choueiri TK,et al.NCCN task force report:optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy[J].Journal of the National Comprehensive Cancer Network,2011,9(Suppl 1):S1-29.
[7] Faragalla H,Youssef YM,Scorilas A,et al.The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma[J].Journalof Molecular Diagnostics,2012,14(4):385-392.
[8] 唐海霞,王 成,路美玲,等.肾透明细胞癌患者血清miR-193a-3p水平增加及早期诊断价值[J].现代检验医学杂志,2015,30(3):43-45,49.
Tang HX, Wang C, Lu ML,et al.Elevated serum miR-193a-3p levelin renal clear cell carcinoma and its early clinical value[J].Journal of Modern Laboratory Medicine,2015,30(3):43-45,49.
[9] 王 静,王 成,张春妮.血清miR-25和miR-100作为食管鳞状细胞癌诊断和预后标志物研究[J].现代检验医学杂志,2015,30(5):17-21.
Wang J,Wang C,Zhang CN.Study on serum miR-25 and miR-100 as diagnostic and prognostic markers for esophageal squamous cell carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(5):17-21.
[10] Xie CM,Wei W,Sun Y.Role of SKP1-CUL1-F-Box-Protein(SCF)E3 ubiquitin ligases in skin cancer[J].Journal of Genetics and Genomics,2013,40(3):97-106.
[11] 田 钰,杨桂芳.FBXO31,Cyclin D1在胃癌中的表达及其临床意义[J].武汉大学学报(医学版),2014,05:707-709,732.
Tian Y, Yang GF.The expression of FBXO31 and Cyclin D1 in gastric cancer and its clinical significance[J].Journal of Hubei Medical University(Medical Edition),2014,35(5):707-709,732.
[12] 张明慧,郭 炜,董稚明,等.食管鳞状细胞癌中FBXO32基因表达及其临床意义[J].临床与实验病理学杂志,2013,29(6):632-636.
Zhang MH,Guo W,Dong ZM,et al.Expression of FBXO32 in esophageal squamous cell carcinoma and its clinical significance[J].Journal of Clinical and Experimental Pathology,2013,29(6):632-636.
[13] Wei CX,Liu JY,Yu ZS,et al.TALEN or Cas9-Rapid,Efficient and Specific Choices for Genome Modifications[J].Journal of Genetics and Genomics,2013,40(6):281-289.
[14] Mo Z,Zu X,Xie Z,et al.Antitumor effect of F-PBF(beta-TrCP)-induced targeted PTTG1 degradation in HeLa cells[J].Journal of Biotechnology,2009,139(1):6-11.